Article Text

Download PDFPDF
Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials


Clofibrate (Atromid-S) reduces serum lipid concentrations in man.1 The results of two large trials of clofibrate in the long-term management of patients with ischaemic heart disease were published last year and have caused much discussion.2 3

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.